Abstract
LKB1 is a tumor susceptibility gene for the Peutz–Jeghers cancer syndrome and is a target for mutational inactivation in sporadic human malignancies. LKB1 encodes a serine/threonine kinase that has critical roles in cell growth, polarity and metabolism. A novel and important function of LKB1 is its ability to regulate the phosphorylation of CREB-regulated transcription co-activators (CRTCs) whose aberrant activation is linked with oncogenic activities. However, the roles and mechanisms of LKB1 and CRTC in the pathogenesis of esophageal cancer have not been previously investigated. In this study, we observed altered LKB1–CRTC signaling in a subset of human esophageal cancer cell lines and patient samples. LKB1 negatively regulates esophageal cancer cell migration and invasion in vitro. Mechanistically, we determined that CRTC signaling becomes activated because of LKB1 loss, which results in the transcriptional activation of specific downstream targets including LYPD3, a critical mediator for LKB1 loss-of-function. Our data indicate that de-regulated LKB1–CRTC signaling might represent a crucial mechanism for esophageal cancer progression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ahn S, Olive M, Aggarwal S, Krylov D, Ginty DD, Vinson C . (1998). A dominant-negative inhibitor of CREB reveals that it is a general mediator of stimulus-dependent transcription of c-fos. Mol Cell Biol 18: 967–977.
Altarejos JY, Goebel N, Conkright MD, Inoue H, Xie J, Arias CM et al. (2008). The Creb1 coactivator Crtc1 is required for energy balance and fertility. Nat Med 14: 1112–1117.
Altarejos JY, Montminy M . (2011). CREB and the CRTC co-activators: sensors for hormonal and metabolic signals. Nat Rev Mol Cell Biol 12: 141–151.
Andl CD, Mizushima T, Nakagawa H, Oyama K, Harada H, Chruma K et al. (2003). Epidermal growth factor receptor mediates increased cell proliferation, migration, and aggregation in esophageal keratinocytes in vitro and in vivo. J Biol Chem 278: 1824–1830.
Breuillaud L, Halfon O, Magistretti PJ, Pralong FP, Cardinaux JR . (2009). Mouse fertility is not dependent on the CREB coactivator Crtc1. Nat Med 15: 989–990; author reply 991.
Carretero J, Medina PP, Pio R, Montuenga LM, Sanchez-Cespedes M . (2004). Novel and natural knockout lung cancer cell lines for the LKB1/STK11 tumor suppressor gene. Oncogene 23: 4037–4040.
Carretero J, Shimamura T, Rikova K, Jackson AL, Wilkerson MD, Borgman CL et al. (2010). Integrative genomic and proteomic analyses identify targets for Lkb1-deficient metastatic lung tumors. Cancer Cell 17: 547–559.
Chen J, Kesari S, Rooney C, Strack PR, Chen J, Shen H et al. (2010). Inhibition of Notch signaling blocks growht of glioblastoma cell lines and tumor. Genes Cancer 1: 822–835.
Chen Y, Li YH, Chen XP, Gong LM, Zhang SP, Chang ZJ et al. (2005). Point mutation at single tyrosine residue of novel oncogene NOK abrogates tumorigenesis in nude mice. Cancer Res 65: 10838–10846.
Conkright MD, Canettieri G, Screaton R, Guzman E, Miraglia L, Hogenesch JB et al. (2003). TORCs: transducers of regulated CREB activity. Mol Cell 12: 413–423.
Coxon A, Rozenblum E, Park YS, Joshi N, Tsurutani J, Dennis PA et al. (2005). Mect1-Maml2 fusion oncogene linked to the aberrant activation of cyclic AMP/CREB regulated genes. Cancer Res 65: 7137–7144.
Enzinger PC, Mayer RJ . (2003). Esophageal cancer. N Engl J Med 349: 2241–2252.
Esteller M, Avizienyte E, Corn PG, Lothe RA, Baylin SB, Aaltonen LA et al. (2000). Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome. Oncogene 19: 164–168.
Giardiello FM, Brensinger JD, Tersmette AC, Goodman SN, Petersen GM, Booker SV et al. (2000). Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 119: 1447–1453.
Guldberg P, thor Straten P, Ahrenkiel V, Seremet T, Kirkin AF, Zeuthen J . (1999). Somatic mutation of the Peutz-Jeghers syndrome gene, LKB1/STK11, in malignant melanoma. Oncogene 18: 1777–1780.
Hansen LV, Laerum OD, Illemann M, Nielsen BS, Ploug M . (2008). Altered expression of the urokinase receptor homologue, C4.4A, in invasive areas of human esophageal squamous cell carcinoma. Int J Cancer 122: 734–741.
Hezel AF, Bardeesy N . (2008). LKB1; linking cell structure and tumor suppression. Oncogene 27: 6908–6919.
Iourgenko V, Zhang W, Mickanin C, Daly I, Jiang C, Hexham JM et al. (2003). Identification of a family of cAMP response element-binding protein coactivators by genome-scale functional analysis in mammalian cells. Proc Natl Acad Sci USA 100: 12147–12152.
Ji H, Ramsey MR, Hayes DN, Fan C, McNamara K, Kozlowski P et al. (2007). LKB1 modulates lung cancer differentiation and metastasis. Nature 448: 807–810.
Jin J, Smith FD, Stark C, Wells CD, Fawcett JP, Kulkarni S et al. (2004). Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization. Curr Biol 14: 1436–1450.
Katoh Y, Takemori H, Lin XZ, Tamura M, Muraoka M, Satoh T et al. (2006). Silencing the constitutive active transcription factor CREB by the LKB1-SIK signaling cascade. FEBS J 273: 2730–2748.
Klein CA, Stoecklein NH . (2009). Lessons from an aggressive cancer: evolutionary dynamics in esophageal carcinoma. Cancer Res 69: 5285–5288.
Komiya T, Coxon A, Park Y, Chen WD, Zajac-Kaye M, Meltzer P et al. (2010). Enhanced activity of the CREB co-activator Crtc1 in LKB1 null lung cancer. Oncogene 29: 1672–1680.
Komiya T, Park Y, Modi S, Coxon AB, Oh H, Kaye FJ . (2006). Sustained expression of Mect1-Maml2 is essential for tumor cell growth in salivary gland cancers carrying the t(11;19) translocation. Oncogene 25: 6128–6132.
Kuwano H, Kato H, Miyazaki T, Fukuchi M, Masuda N, Nakajima M et al. (2005). Genetic alterations in esophageal cancer. Surg Today 35: 7–18.
Lam AK . (2000). Molecular biology of esophageal squamous cell carcinoma. Crit Rev Oncol Hematol 33: 71–90.
Launonen V, Avizienyte E, Loukola A, Laiho P, Salovaara R, Jarvinen H et al. (2000). No evidence of Peutz-Jeghers syndrome gene LKB1 involvement in left-sided colorectal carcinomas. Cancer Res 60: 546–548.
Lee JJ, Natsuizaka M, Ohashi S, Wong GS, Takaoka M, Michaylira CZ et al. (2010). Hypoxia activates the cyclooxygenase-2-prostaglandin E synthase axis. Carcinogenesis 31: 427–434.
Liu L, Yu XZ, Li TS, Song LX, Chen PL, Suo TL et al. (2004). A novel protein tyrosine kinase NOK that shares homology with platelet- derived growth factor/fibroblast growth factor receptors induces tumorigenesis and metastasis in nude mice. Cancer Res 64: 3491–3499.
Luo Z, Zang M, Guo W . (2010). AMPK as a metabolic tumor suppressor: control of metabolism and cell growth. Future Oncol 6: 457–470.
Mahoney CL, Choudhury B, Davies H, Edkins S, Greenman C, Haaften G et al. (2009). LKB1/KRAS mutant lung cancers constitute a genetic subset of NSCLC with increased sensitivity to MAPK and mTOR signalling inhibition. Br J Cancer 100: 370–375.
Makowski L, Hayes DN . (2008). Role of LKB1 in lung cancer development. Br J Cancer 99: 683–688.
Matsumoto S, Iwakawa R, Takahashi K, Kohno T, Nakanishi Y, Matsuno Y et al. (2007). Prevalence and specificity of LKB1 genetic alterations in lung cancers. Oncogene 26: 5911–5918.
Nishihira T, Hashimoto Y, Katayama M, Mori S, Kuroki T . (1993). Molecular and cellular features of esophageal cancer cells. J Cancer Res Clin Oncol 119: 441–449.
Paret C, Bourouba M, Beer A, Miyazaki K, Schnolzer M, Fiedler S et al. (2005). Ly6 family member C4.4A binds laminins 1 and 5, associates with galectin-3 and supports cell migration. Int J Cancer 115: 724–733.
Rodriguez LG, Wu X, Guan JL . (2005). Wound-healing assay. Methods Mol Biol 294: 23–29.
Rosel M, Claas C, Seiter S, Herlevsen M, Zoller M . (1998). Cloning and functional characterization of a new phosphatidyl-inositol anchored molecule of a metastasizing rat pancreatic tumor. Oncogene 17: 1989–2002.
Rowan A, Bataille V, MacKie R, Healy E, Bicknell D, Bodmer W et al. (1999). Somatic mutations in the Peutz-Jeghers (LKB1/STKII) gene in sporadic malignant melanomas. J Invest Dermatol 112: 509–511.
Rustgi AK . (2006). Models of esophageal carcinogenesis. Semin Oncol 33: S57–S58.
Sanchez-Cespedes M . (2007). A role for LKB1 gene in human cancer beyond the Peutz-Jeghers syndrome. Oncogene 26: 7825–7832.
Sanchez-Cespedes M, Parrella P, Esteller M, Nomoto S, Trink B, Engles JM et al. (2002). Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. Cancer Res 62: 3659–3662.
Sattler M, Mohi MG, Pride YB, Quinnan LR, Malouf NA, Podar K et al. (2002). Critical role for Gab2 in transformation by BCR/ABL. Cancer Cell 1: 479–492.
Seiter S, Stassar M, Rappl G, Reinhold U, Tilgen W, Zoller M . (2001). Upregulation of C4.4A expression during progression of melanoma. J Invest Dermatol 116: 344–347.
Shackelford DB, Shaw RJ . (2009). The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer 9: 563–575.
Shimada Y, Imamura M, Wagata T, Yamaguchi N, Tobe T . (1992). Characterization of 21 newly established esophageal cancer cell lines. Cancer 69: 277–284.
Tiainen M, Vaahtomeri K, Ylikorkala A, Makela TP . (2002). Growth arrest by the LKB1 tumor suppressor: induction of p21(WAF1/CIP1). Hum Mol Genet 11: 1497–1504.
Tiainen M, Ylikorkala A, Makela TP . (1999). Growth suppression by Lkb1 is mediated by a G(1) cell cycle arrest. Proc Natl Acad Sci USA 96: 9248–9251.
Tonon G, Modi S, Wu L, Kubo A, Coxon AB, Komiya T et al. (2003). t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway. Nat Genet 33: 208–213.
Vallbohmer D, Brabender J, Metzger R, Holscher AH . (2010). Genetics in the pathogenesis of esophageal cancer: possible predictive and prognostic factors. J Gastrointest Surg 14 (Suppl 1): S75–S80.
van Lier MG, Wagner A, Mathus-Vliegen EM, Kuipers EJ, Steyerberg EW, van Leerdam ME . (2010). High cancer risk in Peutz-Jeghers syndrome: a systematic review and surveillance recommendations. Am J Gastroenterol 105: 1258–1264.
Wingo SN, Gallardo TD, Akbay EA, Liang MC, Contreras CM, Boren T et al. (2009). Somatic LKB1 mutations promote cervical cancer progression. PLoS One 4: e5137.
Wu L, Aster JC, Blacklow SC, Lake R, Artavanis-Tsakonas S, Griffin JD . (2000). MAML1, a human homologue of Drosophila mastermind, is a transcriptional co-activator for NOTCH receptors. Nat Genet 26: 484–489.
Wu L, Liu J, Gao P, Nakamura M, Cao Y, Shen H et al. (2005). Transforming activity of MECT1-MAML2 fusion oncoprotein is mediated by constitutive CREB activation. EMBO J 24: 2391–2402.
Wurfel J, Seiter S, Stassar M, Claas A, Klas R, Rosel M et al. (2001). Cloning of the human homologue of the metastasis-associated rat C4.4A. Gene 262: 35–41.
Acknowledgements
We thank Jenny Huang for critical reading of our paper, Marda Jorgensen for helping with immunohistochemical staining and the University of Florida CTSI Biorepository for providing human esophageal tumor samples. This work was supported in part by the University of Florida Shands Cancer Center Startup fund (L Wu).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Oncogene website
Supplementary information
Rights and permissions
About this article
Cite this article
Gu, Y., Lin, S., Li, JL. et al. Altered LKB1/CREB-regulated transcription co-activator (CRTC) signaling axis promotes esophageal cancer cell migration and invasion. Oncogene 31, 469–479 (2012). https://doi.org/10.1038/onc.2011.247
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2011.247
Keywords
This article is cited by
-
What turns CREB on? And off? And why does it matter?
Cellular and Molecular Life Sciences (2020)
-
PAK4 signaling in health and disease: defining the PAK4–CREB axis
Experimental & Molecular Medicine (2019)
-
Keratin 14-high subpopulation mediates lung cancer metastasis potentially through Gkn1 upregulation
Oncogene (2019)
-
Super enhancer inhibitors suppress MYC driven transcriptional amplification and tumor progression in osteosarcoma
Bone Research (2018)
-
ETS1 regulates Twist1 transcription in a KrasG12D/Lkb1−/− metastatic lung tumor model of non-small cell lung cancer
Clinical & Experimental Metastasis (2018)